Search Results - "van Dijk, Karin D"

Refine Results
  1. 1

    Salivation in Parkinson's disease: A scoping review by Verhoeff, Merel C., Koutris, Michail, Vries, Ralph de, Berendse, Henk W., Dijk, Karin D. van, Lobbezoo, Frank

    Published in Gerodontology (01-03-2023)
    “…Objectives We aimed to provide an overview of the available literature that includes both objective assessments (namely hypersalivation and hyposalivation) and…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Parkinson’s disease, temporomandibular disorder pain and bruxism and its clinical consequences: a protocol of a single-centre observational outpatient study by Verhoeff, Merel Charlotte, Koutris, Michail, Berendse, Henk W, van Dijk, Karin D, Lobbezoo, F

    Published in BMJ open (18-04-2022)
    “…IntroductionA recent questionnaire-based study suggested that bruxism and painful temporomandibular disorders (TMD pain) may be more prevalent in patients with…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Inflammatory Blood Biomarkers Are Associated with Long-Term Clinical Disease Severity in Parkinson's Disease by Hepp, Dagmar H, van Wageningen, Thecla A, Kuiper, Kirsten L, van Dijk, Karin D, Oosterveld, Linda P, Berendse, Henk W, van de Berg, Wilma D J

    “…An altered immune response has been identified as a pathophysiological factor in Parkinson's disease (PD). We aimed to identify blood immunity-associated…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Clinicians’ view on the management of oral health in Parkinson’s disease patients: a qualitative study by Verhoeff, Merel C., Thymi, Magdalini, Brandwijk, Arnoud N., Heres, Mark S., Koutris, Michail, Berendse, Henk W., van Dijk, Karin D., Lobbezoo, Frank

    Published in BDJ open (12-05-2023)
    “…Background due to numerous motor and non-motor symptoms, dental treatment in patients with Parkinson’s Disease (PD) can be challenging. Knowledge regarding…”
    Get full text
    Journal Article
  8. 8

    Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: A pathogenetically based approach by van Dijk, Karin D, Teunissen, Charlotte E, Drukarch, Benjamin, Jimenez, Connie R, Groenewegen, Henk J, Berendse, Henk W, van de Berg, Wilma D.J

    Published in Neurobiology of disease (01-09-2010)
    “…Abstract The inaccuracy of the early diagnosis of Parkinson's disease (PD) has been a major incentive for studies aimed at the identification of biomarkers…”
    Get full text
    Journal Article
  9. 9

    Cerebrospinal fluid and plasma clusterin levels in Parkinson's disease by van Dijk, Karin D, Jongbloed, Wesley, Heijst, Johannes A, Teunissen, Charlotte E, Groenewegen, Henk J, Berendse, Henk W, van de Berg, Wilma D.J, Veerhuis, Robert

    Published in Parkinsonism & related disorders (01-12-2013)
    “…Abstract Clusterin is a multifunctional chaperone protein that has repeatedly been linked to Alzheimer's disease (AD) pathogenesis and, more recently, also to…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Parkinson's disease and oral health: A systematic review by Verhoeff, Merel C., Eikenboom, Denise, Koutris, Michail, de Vries, Ralph, Berendse, Henk W., van Dijk, Karin D., Lobbezoo, Frank

    Published in Archives of oral biology (01-07-2023)
    “…in patients with Parkinson's Disease (PD), oral health can be affected by motor and non-motor symptoms and/or medication use. Therefore, the aim was to…”
    Get full text
    Journal Article
  12. 12

    Orofacial pain and dysfunction in patients with Parkinson's disease: A scoping review by Verhoeff, Merel C., Koutris, Michail, Tambach, Sharine, Eikenboom, Denise, Vries, Ralph, Berendse, Henk W., Dijk, Karin D., Lobbezoo, Frank

    Published in European journal of pain (01-11-2022)
    “…Background Parkinson's disease (PD) is commonly known as a disorder that affects the smooth performance of body movements. In addition to the motor…”
    Get full text
    Journal Article
  13. 13

    The therapeutic potential of opioids in narcolepsy type 1: A systematic literature review and questionnaire study by Gool, Jari K., van Heese, Eva M., Schinkelshoek, Mink S., Remmerswaal, Aniek, Lammers, Gert Jan, van Dijk, Karin D., Fronczek, Rolf

    Published in Sleep medicine (01-09-2023)
    “…Narcolepsy type 1 is a primary sleep disorder caused by deficient hypocretin transmission leading to excessive daytime sleepiness and cataplexy. Opioids have…”
    Get full text
    Journal Article
  14. 14

    Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease by van Dijk, Karin D., Persichetti, Emanuele, Chiasserini, Davide, Eusebi, Paolo, Beccari, Tommaso, Calabresi, Paolo, Berendse, Henk W., Parnetti, Lucilla, van de Berg, Wilma D. J.

    Published in Movement disorders (01-06-2013)
    “…ABSTRACT Parkinson's disease (PD) is characterized neuropathologically by the cytoplasmic accumulation of misfolded α‐synuclein in specific brain regions. The…”
    Get full text
    Journal Article
  15. 15

    Clusterin Levels in Plasma Predict Cognitive Decline and Progression to Alzheimer's Disease by Jongbloed, Wesley, van Dijk, Karin D, Mulder, Sandra D, van de Berg, Wilma D J, Blankenstein, Marinus A, van der Flier, Wiesje, Veerhuis, Robert

    Published in Journal of Alzheimer's disease (26-06-2015)
    “…Increased clusterin levels have been reported in brain, cerebrospinal fluid (CSF), and plasma of Alzheimer's disease (AD) patients. Because changes are also…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Is Disturbed Intracortical Excitability a Stable Trait of Chronic Insomnia? A Study Using Transcranial Magnetic Stimulation Before and After Multimodal Sleep Therapy by van der Werf, Ysbrand D, Altena, Ellemarije, van Dijk, Karin D, Strijers, Rob L.M, De Rijke, Wim, Stam, Cornelis J, van Someren, Eus J.W

    Published in Biological psychiatry (1969) (15-11-2010)
    “…Background Chronic insomnia is a poorly understood disorder. Risk factors for developing chronic insomnia are largely unknown, yet disturbances in brain…”
    Get full text
    Journal Article
  18. 18

    CSF α-synuclein does not discriminate dementia with Lewy bodies from Alzheimer's disease by Reesink, Fransje E, Lemstra, Afina W, van Dijk, Karin D, Berendse, Henk W, van de Berg, Wilma D J, Klein, Martin, Blankenstein, Marinus A, Scheltens, Philip, Verbeek, Marcel M, van der Flier, Wiesje M

    Published in Journal of Alzheimer's disease (01-01-2010)
    “…In this study, we assessed whether cerebrospinal fluid (CSF) levels of the biomarker α-synuclein have a diagnostic value in differential diagnosis of dementia…”
    Get more information
    Journal Article
  19. 19

    The Proteome of the Locus Ceruleus in Parkinson's Disease: Relevance to Pathogenesis by van Dijk, Karin D., Berendse, Henk W., Drukarch, Benjamin, Fratantoni, Silvina A., Pham, Thang V., Piersma, Sander R., Huisman, Evelien, Brevé, John J.P., Groenewegen, Henk J., Jimenez, Connie R., van de Berg, Wilma D.J.

    Published in Brain pathology (Zurich, Switzerland) (01-07-2012)
    “…The locus ceruleus is among the earliest affected brain regions in Parkinson's disease (PD) showing Lewy body pathology and neuronal loss. To improve our…”
    Get full text
    Journal Article
  20. 20

    Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus by Vriend, Chris, Raijmakers, Pieter, Veltman, Dick J, van Dijk, Karin D, van der Werf, Ysbrand D, Foncke, Elisabeth M J, Smit, Jan H, Berendse, Henk W, van den Heuvel, Odile A

    “…Background Depression is a common neuropsychiatric symptom in Parkinson's disease (PD). In previous research, PD-related depression was associated with…”
    Get full text
    Journal Article